发明名称 |
S(+) Desmethylselegiline and its use to treat ADHD |
摘要 |
The present invention provides novel compositions and methods for using the S(+) enantiomer of desmethylselegiline (N-methyl-N-(prop-2-ynyl)-2-aminophenylpropane), for the treatment of selegiline-responsive diseases and conditions. Diseases and conditions responsive to selegiline include those produced by neuronal degeneration or neuronal trauma and those due to immune system dysfunction. Effective dosages are a daily dose of at least about 0.015 mg/kg of body weight.
|
申请公布号 |
US6759053(B2) |
申请公布日期 |
2004.07.06 |
申请号 |
US20020251727 |
申请日期 |
2002.09.20 |
申请人 |
SOMERSET PHARMACEUTICALS, INC. |
发明人 |
DISANTO ANTHONY R. |
分类号 |
A61K31/135;A61K31/137;A61K45/06;(IPC1-7):A61F13/00 |
主分类号 |
A61K31/135 |
代理机构 |
|
代理人 |
|
主权项 |
|
地址 |
|